Literature DB >> 11734090

The relationship between quality of life and adherence to treatment.

M I Nunes1.   

Abstract

Hypertension is a preventable condition, and the outcomes of clinical trials have established that its treatment reduces cardiovascular morbidity and mortality. Although awareness about the disease has improved in the past two decades, the reality is that many people remain untreated or not adequately controlled. The treatment of hypertension is usually long term, and its success will depend on the effects of the drug regimen on the patient's quality of life. The relationship between quality of life and compliance is complex and merits careful study. Monitoring quality of life may be one of the best ways of improving adherence to treatment. Therefore, when developing an approach to the treatment of hypertension, physicians should take into consideration the impact of different antihypertensives on the patient's overall well being, and along with the side effects and contraindications, quality-of-life issues may determine the choice of medication.

Entities:  

Mesh:

Year:  2001        PMID: 11734090     DOI: 10.1007/s11906-001-0007-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  19 in total

Review 1.  Guidelines for assessing outcomes of antihypertensive treatment.

Authors:  M Weber
Journal:  Am J Cardiol       Date:  1999-07-22       Impact factor: 2.778

2.  Assessment of quality of life by patient and spouse during antihypertensive therapy with atenolol and nifedipine gastrointestinal therapeutic system.

Authors:  M A Testa; N K Hollenberg; R B Anderson; G H Williams
Journal:  Am J Hypertens       Date:  1991-04       Impact factor: 2.689

3.  Prevalence, treatment, and control of hypertension by sociodemographic factors among the Dutch elderly.

Authors:  C T van Rossum; H van de Mheen; J C Witteman; A Hofman; J P Mackenbach; D E Grobbee
Journal:  Hypertension       Date:  2000-03       Impact factor: 10.190

4.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

5.  The effects of antihypertensive therapy on the quality of life.

Authors:  S H Croog; S Levine; M A Testa; B Brown; C J Bulpitt; C D Jenkins; G L Klerman; G H Williams
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

Review 6.  Assessing patient wellness: new perspectives on quality of life and compliance.

Authors:  G H Williams
Journal:  Am J Hypertens       Date:  1998-11       Impact factor: 2.689

7.  Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine.

Authors:  A E Fletcher; C J Bulpitt; D M Chase; W C Collins; C D Furberg; T K Goggin; A J Hewett; A M Neiss
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

Review 8.  Elderly hypertensives and quality of life: some methodological considerations.

Authors:  M E Kitler
Journal:  Eur Heart J       Date:  1993-01       Impact factor: 29.983

9.  Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group.

Authors:  M A Testa; R B Anderson; J F Nackley; N K Hollenberg
Journal:  N Engl J Med       Date:  1993-04-01       Impact factor: 91.245

Review 10.  Managing hypertension in general practice: can we do better?

Authors:  J Hosie; I Wiklund
Journal:  J Hum Hypertens       Date:  1995-07       Impact factor: 3.012

View more
  6 in total

1.  Can a Multifaceted Intervention Including Motivational Interviewing Improve Medication Adherence, Quality of Life, and Mortality Rates in Older Patients Undergoing Coronary Artery Bypass Surgery? A Multicenter, Randomized Controlled Trial with 18-Month Follow-Up.

Authors:  Chung-Ying Lin; Mehdi Yaseri; Amir H Pakpour; Dan Malm; Anders Broström; Bengt Fridlund; Andrea Burri; Thomas L Webb
Journal:  Drugs Aging       Date:  2017-02       Impact factor: 3.923

2.  Does treatment adherence correlates with health related quality of life? Findings from a cross sectional study.

Authors:  Fahad Saleem; Mohamed Azmi Hassali; Asrul Akmal Shafie; George A Awad; Muhammad Atif; Noman ul Haq; Hisham Aljadhey; Maryam Farooqui
Journal:  BMC Public Health       Date:  2012-04-30       Impact factor: 3.295

3.  Risk factors for nonadherence to warfarin: results from the IN-RANGE study.

Authors:  Alec B Platt; A Russell Localio; Colleen M Brensinger; Dean G Cruess; Jason D Christie; Robert Gross; Catherine S Parker; Maureen Price; Joshua P Metlay; Abigail Cohen; Craig W Newcomb; Brian L Strom; Mitchell S Laskin; Stephen E Kimmel
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-09       Impact factor: 2.890

4.  Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials.

Authors:  Giuseppe Mancia; Helmut Schumacher
Journal:  Patient Prefer Adherence       Date:  2011-12-23       Impact factor: 2.711

5.  The impact of drug related problems on health-related quality of life among hypertensive patients in Jordan.

Authors:  Rana Abu Farha; Akram Saleh; Salah Aburuz
Journal:  Pharm Pract (Granada)       Date:  2017-08-23

6.  Health-related quality of life and blood pressure control in hypertensive patients with and without complications.

Authors:  Josiane Lima de Gusmão; Decio Mion; Angela Maria Geraldo Pierin
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.